biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s): BIOAF

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

TSXV:BTI.H - Post by User

biOasis Technologies Ord Shs > Another Question

<< Previous

Bullboard Posts

Next >>

Comment by greaterfoolFredon Dec 22, 2022 4:46pm

106 Views

Post# 35188073

RE:RE:RE:Another Question

When BTI anounced that it would be borrowing some cash, I thought there might be a chance for JD to get paid. Now maybe not so much. And I was trying to hint that he should stop before things get dangerous. I think he deserves something for all of the information he has provided.

<< Previous

Bullboard Posts

Next >>

Changing Europe’s dependency on HREE from China